# Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults

> **NCT03956524** · PHASE1 · COMPLETED · sponsor: **EuBiologics Co.,Ltd** · enrollment: 75 (actual)

## Conditions studied

- Typhoid Fever

## Interventions

- **BIOLOGICAL:** EuTCV
- **BIOLOGICAL:** Typbar-TCV™
- **BIOLOGICAL:** Typhim Vi®

## Key facts

- **NCT ID:** NCT03956524
- **Lead sponsor:** EuBiologics Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-16
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03956524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03956524, "Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03956524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*